<?xml version="1.0" encoding="UTF-8"?>
<doc:document xmlns:doc="http://www.elsevier.com/xml/document/schema"
              xmlns:dp="http://www.elsevier.com/xml/common/doc-properties/schema"
              xmlns:cps="http://www.elsevier.com/xml/common/consyn-properties/schema"
              xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
              xmlns:dct="http://purl.org/dc/terms/"
              xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/"
              xmlns:oa="http://vtw.elsevier.com/data/ns/properties/OpenAccess-1/"
              xmlns:bam="http://vtw.elsevier.com/data/voc/ns/bam-vtw-1/"
              xmlns:cp="http://vtw.elsevier.com/data/ns/properties/Copyright-1/"
              xmlns:cja="http://www.elsevier.com/xml/cja/schema"
              xmlns:ja="http://www.elsevier.com/xml/ja/schema"
              xmlns:bk="http://www.elsevier.com/xml/bk/schema"
              xmlns:ce="http://www.elsevier.com/xml/common/schema"
              xmlns:mml="http://www.w3.org/1998/Math/MathML"
              xmlns:cals="http://www.elsevier.com/xml/common/cals/schema"
              xmlns:tb="http://www.elsevier.com/xml/common/table/schema"
              xmlns:sa="http://www.elsevier.com/xml/common/struct-aff/schema"
              xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/schema"
              xmlns:xlink="http://www.w3.org/1999/xlink">
   <rdf:RDF>
      <rdf:Description rdf:about="http://dx.doi.org/10.1016/j.dib.2021.107744">
         <dct:format>application/xml</dct:format>
         <dct:title>Microencapsulated Sertoli cells sustain myoblast proliferation without affecting the myogenic potential. In vitro data</dct:title>
         <dct:creator>Sara Chiappalupi</dct:creator>
         <dct:creator>Laura Salvadori</dct:creator>
         <dct:creator>Francesca Mancuso</dct:creator>
         <dct:creator>Iva Arato</dct:creator>
         <dct:creator>Mario Calvitti</dct:creator>
         <dct:creator>Francesca Riuzzi</dct:creator>
         <dct:creator>Riccardo Calafiore</dct:creator>
         <dct:creator>Giovanni Luca</dct:creator>
         <dct:creator>Guglielmo Sorci</dct:creator>
         <dct:subject>
            <rdf:Bag>
               <rdf:li>Sertoli cell</rdf:li>
               <rdf:li>Microencapsulation</rdf:li>
               <rdf:li>Myoblast</rdf:li>
               <rdf:li>Fusion index</rdf:li>
               <rdf:li>Myogenic potential</rdf:li>
               <rdf:li>Myoblast proliferation</rdf:li>
            </rdf:Bag>
         </dct:subject>
         <dct:description>Data in Brief 40 (2022). doi:10.1016/j.dib.2021.107744</dct:description>
         <prism:aggregationType>journal</prism:aggregationType>
         <prism:publicationName>Data in Brief</prism:publicationName>
         <prism:copyright>© 2021 The Authors. Published by Elsevier Inc.</prism:copyright>
         <dct:publisher>Elsevier Inc.</dct:publisher>
         <prism:issn>2352-3409</prism:issn>
         <prism:volume>40</prism:volume>
         <prism:coverDisplayDate>February 2022</prism:coverDisplayDate>
         <prism:doi>10.1016/j.dib.2021.107744</prism:doi>
         <prism:url>http://dx.doi.org/10.1016/j.dib.2021.107744</prism:url>
         <dct:identifier>doi:10.1016/j.dib.2021.107744</dct:identifier>
         <bam:articleNumber>107744</bam:articleNumber>
         <oa:openAccessInformation>
            <oa:openAccessStatus xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">http://vtw.elsevier.com/data/voc/oa/OpenAccessStatus#Full</oa:openAccessStatus>
            <oa:openAccessEffective xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">2021-12-21T17:28:25Z</oa:openAccessEffective>
            <oa:sponsor xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
               <oa:sponsorName>Italian Institutions (CRUI) 2020</oa:sponsorName>
               <oa:sponsorType>http://vtw.elsevier.com/data/voc/oa/SponsorType#FundingBody</oa:sponsorType>
            </oa:sponsor>
            <oa:userLicense xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">http://creativecommons.org/licenses/by-nc-nd/4.0/</oa:userLicense>
         </oa:openAccessInformation>
         <cp:licenseLine xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">This is an open access article under the CC BY-NC-ND license.</cp:licenseLine>
      </rdf:Description>
   </rdf:RDF>
   <dp:document-properties>
      <dp:aggregation-type>Journals</dp:aggregation-type>
      <dp:version-number>S300.2</dp:version-number>
   </dp:document-properties>
   <ja:article docsubtype="dat" version="5.6" xml:lang="en">
      <ja:item-info>
         <ja:jid>DIB</ja:jid>
         <ja:aid>107744</ja:aid>
         <ce:article-number>107744</ce:article-number>
         <ce:pii>S2352-3409(21)01019-2</ce:pii>
         <ce:doi>10.1016/j.dib.2021.107744</ce:doi>
         <ce:copyright type="unknown" year="2021"/>
      </ja:item-info>
      <ja:head>
         <ce:dochead id="dchd0001">
            <ce:textfn id="dhtxt0001">Data Article</ce:textfn>
         </ce:dochead>
         <ce:title id="tte0002">Microencapsulated Sertoli cells sustain myoblast proliferation without affecting the myogenic potential. <ce:italic>In vitro</ce:italic> data</ce:title>
         <ce:author-group id="aut0001">
            <ce:author id="au0001"
                       author-id="S2352340921010192-60f9a18b37193999e5cdc152fba85c7f"
                       orcid="0000-0001-8377-0665">
               <ce:given-name>Sara</ce:given-name>
               <ce:surname>Chiappalupi</ce:surname>
               <ce:contributor-role role="http://credit.niso.org/contributor-roles/conceptualization">Conceptualization</ce:contributor-role>
               <ce:contributor-role role="http://credit.niso.org/contributor-roles/investigation">Investigation</ce:contributor-role>
               <ce:contributor-role role="http://credit.niso.org/contributor-roles/visualization">Visualization</ce:contributor-role>
               <ce:contributor-role role="http://credit.niso.org/contributor-roles/writing-original-draft">Writing – original draft</ce:contributor-role>
               <ce:cross-ref refid="aff0001">
                  <ce:sup loc="post">a</ce:sup>
               </ce:cross-ref>
               <ce:cross-ref refid="aff0003">
                  <ce:sup loc="post">c</ce:sup>
               </ce:cross-ref>
               <ce:cross-ref refid="aff0006">
                  <ce:sup loc="post">f</ce:sup>
               </ce:cross-ref>
               <ce:cross-ref refid="afn1">
                  <ce:sup loc="post">#</ce:sup>
               </ce:cross-ref>
            </ce:author>
            <ce:author id="au0002"
                       author-id="S2352340921010192-ca554238f16eadcd234eb58725877690">
               <ce:given-name>Laura</ce:given-name>
               <ce:surname>Salvadori</ce:surname>
               <ce:contributor-role role="http://credit.niso.org/contributor-roles/conceptualization">Conceptualization</ce:contributor-role>
               <ce:contributor-role role="http://credit.niso.org/contributor-roles/investigation">Investigation</ce:contributor-role>
               <ce:contributor-role role="http://credit.niso.org/contributor-roles/visualization">Visualization</ce:contributor-role>
               <ce:contributor-role role="http://credit.niso.org/contributor-roles/writing-original-draft">Writing – original draft</ce:contributor-role>
               <ce:cross-ref refid="aff0002">
                  <ce:sup loc="post">b</ce:sup>
               </ce:cross-ref>
               <ce:cross-ref refid="aff0003">
                  <ce:sup loc="post">c</ce:sup>
               </ce:cross-ref>
               <ce:cross-ref refid="aff0006">
                  <ce:sup loc="post">f</ce:sup>
               </ce:cross-ref>
               <ce:cross-ref refid="afn1">
                  <ce:sup loc="post">#</ce:sup>
               </ce:cross-ref>
            </ce:author>
            <ce:author id="au0003"
                       author-id="S2352340921010192-7ac39ab102f1800ef6c22af637446da4">
               <ce:given-name>Francesca</ce:given-name>
               <ce:surname>Mancuso</ce:surname>
               <ce:contributor-role role="http://credit.niso.org/contributor-roles/conceptualization">Conceptualization</ce:contributor-role>
               <ce:contributor-role role="http://credit.niso.org/contributor-roles/resources">Resources</ce:contributor-role>
               <ce:contributor-role role="http://credit.niso.org/contributor-roles/investigation">Investigation</ce:contributor-role>
               <ce:contributor-role role="http://credit.niso.org/contributor-roles/validation">Validation</ce:contributor-role>
               <ce:contributor-role role="http://credit.niso.org/contributor-roles/visualization">Visualization</ce:contributor-role>
               <ce:cross-ref refid="aff0001">
                  <ce:sup loc="post">a</ce:sup>
               </ce:cross-ref>
               <ce:cross-ref refid="afn1">
                  <ce:sup loc="post">#</ce:sup>
               </ce:cross-ref>
            </ce:author>
            <ce:author id="au0004"
                       author-id="S2352340921010192-e2bb7eb1623e9e9fe5d1d12ccc12dc1e">
               <ce:given-name>Iva</ce:given-name>
               <ce:surname>Arato</ce:surname>
               <ce:contributor-role role="http://credit.niso.org/contributor-roles/resources">Resources</ce:contributor-role>
               <ce:contributor-role role="http://credit.niso.org/contributor-roles/validation">Validation</ce:contributor-role>
               <ce:cross-ref refid="aff0001">
                  <ce:sup loc="post">a</ce:sup>
               </ce:cross-ref>
            </ce:author>
            <ce:author id="au0005"
                       author-id="S2352340921010192-d646477733c7031c0a114bbe985dbb87">
               <ce:given-name>Mario</ce:given-name>
               <ce:surname>Calvitti</ce:surname>
               <ce:contributor-role role="http://credit.niso.org/contributor-roles/resources">Resources</ce:contributor-role>
               <ce:cross-ref refid="aff0001">
                  <ce:sup loc="post">a</ce:sup>
               </ce:cross-ref>
            </ce:author>
            <ce:author id="au0006"
                       author-id="S2352340921010192-ef39d3f17bc4374dbaa7466489406401"
                       orcid="0000-0001-7908-3379">
               <ce:given-name>Francesca</ce:given-name>
               <ce:surname>Riuzzi</ce:surname>
               <ce:contributor-role role="http://credit.niso.org/contributor-roles/writing-review-editing">Writing – review &amp; editing</ce:contributor-role>
               <ce:cross-ref refid="aff0001">
                  <ce:sup loc="post">a</ce:sup>
               </ce:cross-ref>
               <ce:cross-ref refid="aff0003">
                  <ce:sup loc="post">c</ce:sup>
               </ce:cross-ref>
               <ce:cross-ref refid="aff0006">
                  <ce:sup loc="post">f</ce:sup>
               </ce:cross-ref>
            </ce:author>
            <ce:author id="au0007"
                       author-id="S2352340921010192-a294686268db5f9c41e436f92bed7948">
               <ce:given-name>Riccardo</ce:given-name>
               <ce:surname>Calafiore</ce:surname>
               <ce:contributor-role role="http://credit.niso.org/contributor-roles/writing-review-editing">Writing – review &amp; editing</ce:contributor-role>
               <ce:contributor-role role="http://credit.niso.org/contributor-roles/funding-acquisition">Funding acquisition</ce:contributor-role>
               <ce:cross-ref refid="aff0001">
                  <ce:sup loc="post">a</ce:sup>
               </ce:cross-ref>
               <ce:cross-ref refid="aff0004">
                  <ce:sup loc="post">d</ce:sup>
               </ce:cross-ref>
               <ce:cross-ref refid="afn2">
                  <ce:sup loc="post">⁎</ce:sup>
               </ce:cross-ref>
            </ce:author>
            <ce:author id="au0008"
                       author-id="S2352340921010192-a42529bd692059084bfd3920f4c19eb8">
               <ce:given-name>Giovanni</ce:given-name>
               <ce:surname>Luca</ce:surname>
               <ce:contributor-role role="http://credit.niso.org/contributor-roles/supervision">Supervision</ce:contributor-role>
               <ce:contributor-role role="http://credit.niso.org/contributor-roles/writing-review-editing">Writing – review &amp; editing</ce:contributor-role>
               <ce:contributor-role role="http://credit.niso.org/contributor-roles/funding-acquisition">Funding acquisition</ce:contributor-role>
               <ce:cross-ref refid="aff0001">
                  <ce:sup loc="post">a</ce:sup>
               </ce:cross-ref>
               <ce:cross-ref refid="aff0004">
                  <ce:sup loc="post">d</ce:sup>
               </ce:cross-ref>
               <ce:cross-ref refid="aff0005">
                  <ce:sup loc="post">e</ce:sup>
               </ce:cross-ref>
               <ce:cross-ref refid="cor0001">
                  <ce:sup loc="post">⁎</ce:sup>
               </ce:cross-ref>
               <ce:e-address id="ead0001"
                             type="email"
                             xlink:href="mailto:giovanni.luca@unipg.it">giovanni.luca@unipg.it</ce:e-address>
            </ce:author>
            <ce:author id="au0009"
                       author-id="S2352340921010192-2025c9b8f27b5d81a8a710d32b30a93a"
                       orcid="0000-0002-1973-9679">
               <ce:given-name>Guglielmo</ce:given-name>
               <ce:surname>Sorci</ce:surname>
               <ce:contributor-role role="http://credit.niso.org/contributor-roles/supervision">Supervision</ce:contributor-role>
               <ce:contributor-role role="http://credit.niso.org/contributor-roles/writing-review-editing">Writing – review &amp; editing</ce:contributor-role>
               <ce:contributor-role role="http://credit.niso.org/contributor-roles/funding-acquisition">Funding acquisition</ce:contributor-role>
               <ce:cross-ref refid="aff0001">
                  <ce:sup loc="post">a</ce:sup>
               </ce:cross-ref>
               <ce:cross-ref refid="aff0003">
                  <ce:sup loc="post">c</ce:sup>
               </ce:cross-ref>
               <ce:cross-ref refid="aff0004">
                  <ce:sup loc="post">d</ce:sup>
               </ce:cross-ref>
               <ce:cross-ref refid="aff0005">
                  <ce:sup loc="post">e</ce:sup>
               </ce:cross-ref>
               <ce:cross-ref refid="aff0006">
                  <ce:sup loc="post">f</ce:sup>
               </ce:cross-ref>
               <ce:cross-ref refid="cor0001">
                  <ce:sup loc="post">⁎</ce:sup>
               </ce:cross-ref>
               <ce:e-address id="ead0002"
                             type="email"
                             xlink:href="mailto:guglielmo.sorci@unipg.it">guglielmo.sorci@unipg.it</ce:e-address>
            </ce:author>
            <ce:affiliation id="aff0001"
                            affiliation-id="S2352340921010192-d7820954ca6a011eb384ec280597987b">
               <ce:label>a</ce:label>
               <ce:textfn id="cetextfn0001">Department of Medicine and Surgery, University of Perugia, Perugia 06132, Italy</ce:textfn>
               <sa:affiliation>
                  <sa:organization>Department of Medicine and Surgery</sa:organization>
                  <sa:organization>University of Perugia</sa:organization>
                  <sa:city>Perugia</sa:city>
                  <sa:postal-code>06132</sa:postal-code>
                  <sa:country>Italy</sa:country>
               </sa:affiliation>
               <ce:source-text id="staff0001">aDepartment of Medicine and Surgery, University of Perugia, Perugia 06132, Italy</ce:source-text>
            </ce:affiliation>
            <ce:affiliation id="aff0002"
                            affiliation-id="S2352340921010192-4f2241723f4eaffacebbeee9a4ab9d4d">
               <ce:label>b</ce:label>
               <ce:textfn id="cetextfn0002">Department of Translational Medicine, University of Piemonte Orientale, Novara 28100, Italy</ce:textfn>
               <sa:affiliation>
                  <sa:organization>Department of Translational Medicine</sa:organization>
                  <sa:organization>University of Piemonte Orientale</sa:organization>
                  <sa:city>Novara</sa:city>
                  <sa:postal-code>28100</sa:postal-code>
                  <sa:country>Italy</sa:country>
               </sa:affiliation>
               <ce:source-text id="staff0002">bDepartment of Translational Medicine, University of Piemonte Orientale, Novara 28100, Italy</ce:source-text>
            </ce:affiliation>
            <ce:affiliation id="aff0003"
                            affiliation-id="S2352340921010192-b5ea313eac4c3e3584e8c379fdcee765">
               <ce:label>c</ce:label>
               <ce:textfn id="cetextfn0003">Interuniversity Institute of Myology (IIM), Perugia 06132, Italy</ce:textfn>
               <sa:affiliation>
                  <sa:organization>Interuniversity Institute of Myology (IIM)</sa:organization>
                  <sa:city>Perugia</sa:city>
                  <sa:postal-code>06132</sa:postal-code>
                  <sa:country>Italy</sa:country>
               </sa:affiliation>
               <ce:source-text id="staff0003">cInteruniversity Institute of Myology (IIM), Perugia 06132, Italy</ce:source-text>
            </ce:affiliation>
            <ce:affiliation id="aff0004"
                            affiliation-id="S2352340921010192-71e72f45ac5c23d59f710fb010e91ecf">
               <ce:label>d</ce:label>
               <ce:textfn id="cetextfn0004">Centro Biotecnologico Internazionale di Ricerca Traslazionale ad indirizzo Endocrino, Metabolico ed Embrio-Riproduttivo (CIRTEMER), Perugia 06132, Italy</ce:textfn>
               <sa:affiliation>
                  <sa:organization>Centro Biotecnologico Internazionale di Ricerca Traslazionale ad indirizzo Endocrino</sa:organization>
                  <sa:organization>Metabolico ed Embrio-Riproduttivo (CIRTEMER)</sa:organization>
                  <sa:city>Perugia</sa:city>
                  <sa:postal-code>06132</sa:postal-code>
                  <sa:country>Italy</sa:country>
               </sa:affiliation>
               <ce:source-text id="staff0004">dCentro Biotecnologico Internazionale di Ricerca Traslazionale ad indirizzo Endocrino, Metabolico ed Embrio-Riproduttivo (CIRTEMER), Perugia 06132, Italy</ce:source-text>
            </ce:affiliation>
            <ce:affiliation id="aff0005"
                            affiliation-id="S2352340921010192-4fd7fd5df0939c37a2c092c925754818">
               <ce:label>e</ce:label>
               <ce:textfn id="cetextfn0005">Centro Universitario di Ricerca sulla Genomica Funzionale (CURGeF), Perugia 06132, Italy</ce:textfn>
               <sa:affiliation>
                  <sa:organization>Centro Universitario di Ricerca sulla Genomica Funzionale (CURGeF)</sa:organization>
                  <sa:city>Perugia</sa:city>
                  <sa:postal-code>06132</sa:postal-code>
                  <sa:country>Italy</sa:country>
               </sa:affiliation>
               <ce:source-text id="staff0005">eCentro Universitario di Ricerca sulla Genomica Funzionale (CURGeF), Perugia 06132, Italy</ce:source-text>
            </ce:affiliation>
            <ce:affiliation id="aff0006"
                            affiliation-id="S2352340921010192-c3f54f32b77369da71f1c2b0bb9b3749">
               <ce:label>f</ce:label>
               <ce:textfn id="cetextfn0006">Consorzio Interuniversitario Biotecnologie (CIB), Trieste 34127, Italy</ce:textfn>
               <sa:affiliation>
                  <sa:organization>Consorzio Interuniversitario Biotecnologie (CIB)</sa:organization>
                  <sa:city>Trieste</sa:city>
                  <sa:postal-code>34127</sa:postal-code>
                  <sa:country>Italy</sa:country>
               </sa:affiliation>
               <ce:source-text id="staff0006">fConsorzio Interuniversitario Biotecnologie (CIB), Trieste 34127, Italy</ce:source-text>
            </ce:affiliation>
            <ce:correspondence id="cor0001">
               <ce:label>⁎</ce:label>
               <ce:text id="cetext0001">Corresponding authors at: Department of Medicine and Surgery, University of Perugia, Perugia 06132, Italy.</ce:text>
               <sa:affiliation>
                  <sa:organization>Department of Medicine and Surgery</sa:organization>
                  <sa:organization>University of Perugia</sa:organization>
                  <sa:city>Perugia</sa:city>
                  <sa:postal-code>06132</sa:postal-code>
                  <sa:country>Italy</sa:country>
               </sa:affiliation>
            </ce:correspondence>
            <ce:footnote id="afn1">
               <ce:label>#</ce:label>
               <ce:note-para id="np001a" view="all">Equally contributed</ce:note-para>
            </ce:footnote>
            <ce:footnote id="afn2">
               <ce:label>⁎</ce:label>
               <ce:note-para id="np001b" view="all">Shared senior authorship</ce:note-para>
            </ce:footnote>
         </ce:author-group>
         <ce:date-received day="20" month="11" year="2021"/>
         <ce:date-revised day="16" month="12" year="2021"/>
         <ce:date-accepted day="20" month="12" year="2021"/>
         <ce:abstract id="abs0001" view="all" class="author">
            <ce:section-title id="cesectitle0001">Abstract</ce:section-title>
            <ce:abstract-sec id="abss0001" view="all">
               <ce:simple-para id="spara003" view="all">Sertoli cells (SeC) isolated from porcine testes have shown direct effects on muscle precursor cells sustaining C2C12 myoblasts proliferation and inhibiting oxidative stress and apoptosis in the early phase of the differentiation process, and stimulating myoblast fusion into myotubes and the expression of markers of myogenic differentiation in the late phase. This suggested that the cocktail of factors secreted by SeC stimulates proliferation in myoblasts without weakening their myogenic potential resulting in the formation of the critical myoblast amount necessary to rebuild the required muscle mass upon a damage. Here, we show that co-culturing C2C12 myoblasts with high doses of SeC microencapsulated in clinical grade alginate-based microcapsules (MC-SeC) for three days in differentiation medium (DM) translates into increased cell numbers and almost absence of myotube formation. However, after removal of MC-SeC, an intense fusion activity into myotubes was observed culminating in a fusion index similar to that of control after additional three days of culture in DM. These data definitely demonstrate that SeC-derived factors preserve the myogenic potential while sustaining cell proliferation in C2C12 myoblasts.</ce:simple-para>
            </ce:abstract-sec>
         </ce:abstract>
         <ce:keywords class="abr" id="pc_90tSSrZFiEHOSA5J7CHmjcyL2YPlefnh" view="all">
            <ce:section-title id="cesectitle0002a">Abbreviations</ce:section-title>
            <ce:keyword id="pc_QOGusVrNOp">
               <ce:text>SeC</ce:text>
               <ce:keyword id="pc_hZIGnPCyVe">
                  <ce:text>Sertoli cells</ce:text>
               </ce:keyword>
            </ce:keyword>
            <ce:keyword id="pc_sI9ZbYRgON">
               <ce:text>MC-SeC</ce:text>
               <ce:keyword id="pc_j1IGe0z3Jh">
                  <ce:text>microencapsulated Sertoli cells</ce:text>
               </ce:keyword>
            </ce:keyword>
            <ce:keyword id="pc_b78tuvFcXs">
               <ce:text>E-MC</ce:text>
               <ce:keyword id="pc_i3rte06Ko9">
                  <ce:text>empty microcapsules</ce:text>
               </ce:keyword>
            </ce:keyword>
            <ce:keyword id="pc_TXmIYCrOWa">
               <ce:text>DM</ce:text>
               <ce:keyword id="pc_jad6ufBNqt">
                  <ce:text>differentiation medium</ce:text>
               </ce:keyword>
            </ce:keyword>
            <ce:keyword id="pc_NtTtTdpp6F">
               <ce:text>AMH</ce:text>
               <ce:keyword id="pc_s7n2WtcoYQ">
                  <ce:text>anti-Müllerian hormone</ce:text>
               </ce:keyword>
            </ce:keyword>
            <ce:keyword id="pc_y8yDkYScpn">
               <ce:text>INSL3</ce:text>
               <ce:keyword id="pc_wlqHq8AFAl">
                  <ce:text>insulin-like3</ce:text>
               </ce:keyword>
            </ce:keyword>
            <ce:keyword id="pc_vH6IGvThbP">
               <ce:text>ASMA</ce:text>
               <ce:keyword id="pc_BirSZWNx5b">
                  <ce:text>alpha-smooth muscle actin</ce:text>
               </ce:keyword>
            </ce:keyword>
            <ce:keyword id="pc_ALapvUtJzw">
               <ce:text>PGP9.5</ce:text>
               <ce:keyword id="pc_TwrcjZ8sz7">
                  <ce:text>protein gene product 9.5</ce:text>
               </ce:keyword>
            </ce:keyword>
            <ce:keyword id="pc_2xRzFSYecb">
               <ce:text>HG-DMEM</ce:text>
               <ce:keyword id="pc_DXPM3hz60V">
                  <ce:text>high-glucose Dulbecco’s modified Eagle’s medium</ce:text>
               </ce:keyword>
            </ce:keyword>
            <ce:keyword id="pc_zaTu77pmBm">
               <ce:text>FBS</ce:text>
               <ce:keyword id="pc_c7s6hLHPXb">
                  <ce:text>foetal bovine serum</ce:text>
               </ce:keyword>
            </ce:keyword>
            <ce:keyword id="pc_QAQYXN3Vn9">
               <ce:text>HS</ce:text>
               <ce:keyword id="pc_52CnQedD14">
                  <ce:text>horse serum</ce:text>
               </ce:keyword>
            </ce:keyword>
            <ce:keyword id="pc_FGoczn6Rof">
               <ce:text>P/S</ce:text>
               <ce:keyword id="pc_N9TQ5H1fmi">
                  <ce:text>penicillin/streptomycin</ce:text>
               </ce:keyword>
            </ce:keyword>
            <ce:keyword id="pc_PYlH12uLbz">
               <ce:text>HBSS</ce:text>
               <ce:keyword id="pc_APP3sQ5m5d">
                  <ce:text>Hanks’ balanced salt solution</ce:text>
               </ce:keyword>
            </ce:keyword>
            <ce:keyword id="pc_cDMsAg76XL">
               <ce:text>TRIS</ce:text>
               <ce:keyword id="pc_Nll4Zp4A3K">
                  <ce:text>tris(hydroxymethyl)aminomethane</ce:text>
               </ce:keyword>
            </ce:keyword>
            <ce:keyword id="pc_3PY5ObnKcy">
               <ce:text>ITS</ce:text>
               <ce:keyword id="pc_UHzYvepWL5">
                  <ce:text>insulin-transferrin-selenium</ce:text>
               </ce:keyword>
            </ce:keyword>
            <ce:keyword id="pc_ZQ7MMlpuR4">
               <ce:text>EB</ce:text>
               <ce:keyword id="pc_ykgdcXJkar">
                  <ce:text>ethidium bromide</ce:text>
               </ce:keyword>
            </ce:keyword>
            <ce:keyword id="pc_7AbH9RNj9S">
               <ce:text>FDA</ce:text>
               <ce:keyword id="pc_uFW3lvMGgI">
                  <ce:text>fluorescein diacetate</ce:text>
               </ce:keyword>
            </ce:keyword>
            <ce:keyword id="pc_qnk7YU0aSj">
               <ce:text>ALG</ce:text>
               <ce:keyword id="pc_Bi77NzWZnJ">
                  <ce:text>sodium alginate</ce:text>
               </ce:keyword>
            </ce:keyword>
            <ce:keyword id="pc_1AxgqnYzX2">
               <ce:text>EDTA</ce:text>
               <ce:keyword id="pc_CPilKrbWVY">
                  <ce:text>ethylene-diamine tetra-acetic acid</ce:text>
               </ce:keyword>
            </ce:keyword>
            <ce:keyword id="pc_4UGzKkiEVF">
               <ce:text>PFA</ce:text>
               <ce:keyword id="pc_rr6PG0uDGe">
                  <ce:text>paraformaldehyde</ce:text>
               </ce:keyword>
            </ce:keyword>
            <ce:keyword id="pc_lXYpgzH3zi">
               <ce:text>BSA</ce:text>
               <ce:keyword id="pc_lum0Th6nkZ">
                  <ce:text>bovine serum albumin</ce:text>
               </ce:keyword>
            </ce:keyword>
            <ce:keyword id="pc_DMQv9DA7wx">
               <ce:text>DAPI</ce:text>
               <ce:keyword id="pc_M4ZFxUBPZO">
                  <ce:text>4′,6-diamidino-2-phenylindole</ce:text>
               </ce:keyword>
            </ce:keyword>
         </ce:keywords>
         <ce:keywords id="keys0001" view="all" class="keyword">
            <ce:section-title id="cesectitle0002">Keywords</ce:section-title>
            <ce:keyword id="key0001">
               <ce:text id="cetext0002">Sertoli cell</ce:text>
            </ce:keyword>
            <ce:keyword id="key0002">
               <ce:text id="cetext0003">Microencapsulation</ce:text>
            </ce:keyword>
            <ce:keyword id="key0003">
               <ce:text id="cetext0004">Myoblast</ce:text>
            </ce:keyword>
            <ce:keyword id="key0004">
               <ce:text id="cetext0005">Fusion index</ce:text>
            </ce:keyword>
            <ce:keyword id="key0005">
               <ce:text id="cetext0006">Myogenic potential</ce:text>
            </ce:keyword>
            <ce:keyword id="key0006">
               <ce:text id="cetext0007">Myoblast proliferation</ce:text>
            </ce:keyword>
         </ce:keywords>
      </ja:head>
   </ja:article>
</doc:document>
